Coeptis Therapeutics Holdings Inc (COEP) Live Share Price, Invest From India

Coeptis Therapeutics Holdings Inc Stock Performance

as on October 31, 2025 at 1:29 am IST

Day's Low
Day's High
$14.51
Day's Price Range
$15.3
$15.05
3.59%
Downside
1.66%
Upside
52 Week's Low
52 Week's High
$2.31
52-Week Price Range
$19.19
$15.05
84.65%
Downside
27.51%
Upside

Coeptis Therapeutics Holdings Inc share price movements today

Previous Close: $14.96
Open: $14.79
Volume: 160.1K
Day's Low - High: $14.51 - $15.3
52 Week Low - High: $2.31 - $19.19

Coeptis Therapeutics Holdings Inc Historical Returns

1 Month Return: -14.32 %
3 Month Return: + 37 %
1 Year Return: + 258.07 %
3 Year Return: -77.67 %
5 Year Return: 0 %

Coeptis Therapeutics Holdings Inc Stock Fundamentals & Key Indicators

Check Coeptis Therapeutics Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$73.4M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-11.8M

Revenue (TTM)

263.6K

Profit Margin

0.00%

Return On Equity TTM

-372.12%

Coeptis Therapeutics Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Coeptis Therapeutics Holdings Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Coeptis Therapeutics Holdings Inc	BUY	$73.4M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$62.4B	291.63%	-505.15	-12.96%
Beone Medicines Ltd	NA	$36.4B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$108.3B	100.24%	30.02	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$69.4B	20.12%	15.7	32.13%

Stock Returns calculator for Coeptis Therapeutics Holdings Inc Stock including INR - Dollar returns

The Coeptis Therapeutics Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Coeptis Therapeutics Holdings Inc investment value today

Current value as on today

₹3,65,714

Returns

₹2,65,714

(+265.71%)

Returns from Coeptis Therapeutics Holdings Inc Stock

₹2,60,048 (+260.05%)

Dollar Returns*

₹5,667 (+5.67%)

Analyst Recommendation on Coeptis Therapeutics Holdings Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Coeptis Therapeutics Holdings Inc. Average target price of $3

Coeptis Therapeutics Holdings Inc Share Price Target

Get share price movements and forecasts by analysts on Coeptis Therapeutics Holdings Inc.

What analysts predicted

-401.67%DOWNSIDE

Target Price

Current Price

$15.05

Analyzed by

7 Analysts

Target

$3.00

Coeptis Therapeutics Holdings Inc target price $3, a slight downside of -401.67% compared to current price of $15.05. According to 7 analysts rating.

Coeptis Therapeutics Holdings Inc Stock’s Investor Sentiment and Interest

Search interest for Coeptis Therapeutics Holdings Inc Stock has increased by 19% in the last 30 days, reflecting an upward trend in search activity.

Time period: October 1, 2025 to October 31, 2025

Change:19% versus previous 30 day period

Coeptis Therapeutics Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	1	-	1	-	1	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-6	-3	-7	-3	-2	-2	-2	-2	-4	-4
EBITDA	-6	-3	-7	-2	-2	-2	-1	-2	-4	-3
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-3	-6	-3	-3	-3	-1	-3	-3	-4
Income Tax Expense	1	0	0	0	0	-1	-	-1	0	-
Net Income	-9	-3	-6	-3	-3	-3	-1	-1	-3	-3
Net Profit Margin	0.00%	0.00%	0.00%	-207.28%	0.00%	-202.11%	0.00%	-104.53%	-4863.27%	-1761.30%

Coeptis Therapeutics Holdings Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	-	-	-
Gross Profit	0	0	-1	-1	-1
Operating Income	-6	-14	-34	-21	-10
EBITDA	-8	-12	-36	-20	-9
Interest Expense	0	0	0	0	0
Depreciation	0	0	1	1	1
Income Before Tax	-9	-13	-37	-21	-10
Income Tax Expense	-2	0	3	3	-1
Net Income	-9	-13	-37	-21	-9
Net Profit Margin	-29764.96%	-17932.00%	0.00%	0.00%	0.00%

Coeptis Therapeutics Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-3	-6	-3	-3	-3	-1	-3	-3	-4
Operating Cash Flow	-1	-1	-1	-1	-1	-1	-1	-2	-2
Investing Cash Flow	0	-	0	-	0	42	0	-	-
Financing Cash Flow	3	0	3	1	1	1	0	6	0
Change in Cash	1	-1	1	0	0	0	0	3	-2

Coeptis Therapeutics Holdings Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2005	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	0	-1	0	-9	-13	-37	-37	-10
Operating Cash Flow	0	0	0	-3	-4	-3	-3	-6
Investing Cash Flow	-	0	1	-75	-1	-	-	-
Financing Cash Flow	0	0	0	2	8	5	5	5
Change in Cash	0	0	0	0	1	1	1	0

Global Institutional Holdings in Coeptis Therapeutics Holdings Inc

Funds	Holdings
Vanguard Group Inc	0.57%
Geode Capital Management, LLC	0.42%
Steward Partners Investment Advisory, LLC	0.02%
Tower Research Capital LLC	0.01%
UBS Group AG	0%

See all

Insights on Coeptis Therapeutics Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, COEP has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 1 year, COEP stock has moved up by 258.1%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 135.5% return, outperforming this stock by 213.2%

About Coeptis Therapeutics Holdings Inc

Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical and technology company. The Company is focused on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio is highlighted by assets licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. It is developing a universal, multi-antigen CAR technology licensed by the University of Pittsburgh (SNAP-CAR), and the GEAR cell therapy and companion diagnostic platforms in collaboration with VyGen-Bio and medical researchers at the Karolinska Institute. Its NexGenAI Affiliates Network platform offers AI-powered marketing software and robotic process automation capabilities. The Company’s subsidiaries include Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc. and SNAP Biosciences, Inc.

Organisation	Coeptis Therapeutics Holdings Inc
Headquarters	105 Bradford Road, Wexford, PA, United States, 15090
CEO	Mr. David Mehalick
E-voting on shares	Click here to vote

Key Management of Coeptis Therapeutics Holdings Inc

Name	Title
Mr. David Mehalick	Co-Founder, Chairman of the Board, CEO & President
Ms. Christine Elise Sheehy	Co-Founder and VP of Compliance & Corporate Secretary
Mr. Daniel Alexander Yerace	Co-Founder, VP of Operations & Director
Mr. Brian Cogley M.B.A.	Chief Financial Officer

FAQs

What is Coeptis Therapeutics Holdings Inc share price today?

Coeptis Therapeutics Holdings Inc share price today is $15.05 as on October 31, 2025 at 1:29 am IST at the close of the market. Coeptis Therapeutics Holdings Inc share today touched a day high of $15.3 and a low of $14.51.

What is the 52 week high and 52 week low for Coeptis Therapeutics Holdings Inc share?

Coeptis Therapeutics Holdings Inc share touched a 52 week high of $19.19 on September 23, 2025 and a 52 week low of $2.31 on December 31, 2024. Coeptis Therapeutics Holdings Inc stock price today i.e. October 31, 2025 at 1:29 am IST is closed at $15.05,which is 21.57% down from its 52 week high and 551.52% up from its 52 week low.

What is Coeptis Therapeutics Holdings Inc's market capitalisation today?

Coeptis Therapeutics Holdings Inc market capitalisation is $0.00T as on October 31, 2025 at 1:29 am IST.

How to invest in Coeptis Therapeutics Holdings Inc Stock (COEP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Coeptis Therapeutics Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Coeptis Therapeutics Holdings Inc Shares that will get you 0.0997 shares as per Coeptis Therapeutics Holdings Inc share price of $15.05 per share as on October 31, 2025 at 1:29 am IST.

What is the minimum amount required to buy Coeptis Therapeutics Holdings Inc Stock (COEP) from India?

Indian investors can start investing in Coeptis Therapeutics Holdings Inc (COEP) shares with as little as ₹88.686 or $1 (as of October 31, 2025 at 5:44 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹886.86 in Coeptis Therapeutics Holdings Inc stock (as per the Rupee-Dollar exchange rate as on October 31, 2025 at 5:44 am IST). Based on Coeptis Therapeutics Holdings Inc share’s latest price of $15.05 as on October 31, 2025 at 1:29 am IST, you will get 0.6645 shares of Coeptis Therapeutics Holdings Inc. Learn more about fractional shares .